Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 10/20 | 0.41 |
| ▸ | ESR1 | P03372 | 9/20 | 0.41 |
| ▸ | ACHE | P22303 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12156965 | 0.76 | TDP1 (0.42) | CYP3A4ALOX15ACHE | |
| Hydrochloric Acid SCHEMBL9445172 | 0.74 | ALDH1A1 (0.41) | CYP3A4ESR2TSHRHSD17B1 | |
| Hydrochloric Acid SCHEMBL9445170 | 0.74 | ALDH1A1 (0.41) | CYP3A4ESR2TSHRHSD17B1 | |
| SCHEMBL8499168 | 0.73 | ALDH1A1 (0.35) | ALOX15 | |
| Hydrochloric Acid SCHEMBL8948391 | 0.73 | ALDH1A1 (0.39) | CYP3A4TSHRHSD17B1 | |
| SCHEMBL111298 | 0.73 | CYP3A4 (0.41) | CYP3A4HTR2BTSHR | |
| Hydrochloric Acid SCHEMBL239363 | 0.71 | CYP3A4 (0.40) | CYP3A4HTR2BTSHR | |
| Hydrochloric Acid SCHEMBL8497331 | 0.71 | ALDH1A1 (0.33) | ALOX15 | |
| SCHEMBL3421204 | 0.71 | CYP2A6 (0.43) | HSD17B1 | |
| Hydrochloric Acid SCHEMBL11034510 | 0.71 | MCL1 (0.41) | CYP3A4ALOX15TSHRRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9126899-B2 | Photosensitive azobenzene derivative | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2015-09-08 | — | — | US | disclosed |
| US-20140323704-A1 | PHOTOSENSITIVE AZOBENZENE DERIVATIVE | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2014-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140323704-A1 | PHOTOSENSITIVE AZOBENZENE DERIVATIVE | CRY1, AKR1B10, CYP1B1 | CYP3A4 52/4885CHRM1 254/4885ALOX15 2105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.